Kymera Therapeutics, Inc.

XTX Topco Ltd KYMR
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/14/2026
Shares
61,501
Value ($000)
7,052
Weight
0.1%
2023 Q3 - 2026 Q2 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).